Pharma - Industry – Focus

 

Custom Search

ICT receives grant for Brucellosis vaccine

Institute of Chemical Technology (ICT), Mumbai has received a prestigious grant from Bill & Melinda Gates Foundation to develop the first green nanovaccine for nasal immunization against brucellosis. Prof. Vandana Patravale, ICT, Matunga was awarded USD100,000 in phase I of Grand Challenges Explorations Round 11 for developing the cost-effective vaccine technology from over 2700 applications. The sub-unit nanovaccine aims to confer long term protective immunity to humans and livestock population. Currently, Brucellosis is a zoonotic bacterial infection with a potential to be exploited as a bioweapon, and currently no human vaccine is available for treatment

Custom Search

Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202   Mobile : 0-97898-37940 email : ibischennai@gmail.com Privacy Policy